Literature DB >> 25243549

Preoperative Pancreatic Resection (PREPARE) score: a prospective multicenter-based morbidity risk score.

Faik G Uzunoglu1, Matthias Reeh, Eik Vettorazzi, Till Ruschke, Philipp Hannah, Michael F Nentwich, Yogesh K Vashist, Dean Bogoevski, Alexandra König, Monika Janot, Francesca Gavazzi, Alessandro Zerbi, Valentina Todaro, Giuseppe Malleo, Waldemar Uhl, Marco Montorsi, Claudio Bassi, Jakob R Izbicki, Maximilian Bockhorn.   

Abstract

OBJECTIVES: Development of a simple preoperative risk score to predict morbidity related to pancreatic surgery.
BACKGROUND: Pancreatic surgery is standardized with little technical diversity among institutions and unchanging morbidity and mortality rates in recent years. Preoperative identification of high-risk patients is potentially one of the rare avenues for improving the clinical course of patients undergoing pancreatic surgery.
METHODS: Using a prospectively collected multicenter database of patients undergoing pancreatic surgery (n=703), surgical complications were classified according to the Clavien-Dindo classification. A new scoring system for preoperative identification of high-risk patients that included only objective preoperatively assessable variables was developed using a multivariate regression model. Subsequently, this scoring system was prospectively validated from 2011 to 2013 (n=429) in a multicenter setting.
RESULTS: Eight independent preoperatively assessable variables were identified and included in the scoring system: systolic blood pressure, heart rate, hemoglobin level, albumin level, ASA (American Society of Anesthesiologists) score, surgical procedure, elective surgery or not, and disease of pancreatic origin or not. On the basis of 3 subgroups (low risk, intermediate risk, high risk), the proposed scoring system reached an accuracy of 75% for correctly predicting occurrence or nonoccurrence of major surgical complications in 80% of all analyzed patients within the validation cohort (c-statistic index=0.709, P<0.001, 95% confidence interval=0.657-0.760).
CONCLUSIONS: We present an easily applied scoring system with convincing accuracy for identifying low-risk and high-risk patients. In contrast to other systems, the score is exclusively based on objective preoperatively assessable characteristics and can be rapidly and easily calculated.

Entities:  

Mesh:

Year:  2014        PMID: 25243549     DOI: 10.1097/SLA.0000000000000946

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  15 in total

Review 1.  Biomarkers in pancreatic ductal adenocarcinoma.

Authors:  J Gallego; C López; R Pazo-Cid; F López-Ríos; A Carrato
Journal:  Clin Transl Oncol       Date:  2017-06-14       Impact factor: 3.405

Review 2.  Enhanced recovery pathways in pancreatic surgery: State of the art.

Authors:  Nicolò Pecorelli; Sara Nobile; Stefano Partelli; Luca Cardinali; Stefano Crippa; Gianpaolo Balzano; Luigi Beretta; Massimo Falconi
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

3.  Centralization of Pancreatic Surgery in Europe.

Authors:  Adam Polonski; Jakob R Izbicki; Faik G Uzunoglu
Journal:  J Gastrointest Surg       Date:  2019-04-29       Impact factor: 3.452

4.  Correlation between the skeletal muscle index and surgical outcomes of pancreaticoduodenectomy.

Authors:  Kenta Sui; Takehiro Okabayshi; Jun Iwata; Sojiro Morita; Tatsuaki Sumiyoshi; Tatsuo Iiyama; Yasuhiro Shimada
Journal:  Surg Today       Date:  2017-12-28       Impact factor: 2.549

Review 5.  Surgery for pancreatic ductal adenocarcinoma.

Authors:  R Vera; L Díez; E Martín Pérez; J C Plaza; A Sanjuanbenito; A Carrato
Journal:  Clin Transl Oncol       Date:  2017-06-23       Impact factor: 3.405

6.  Is routine CT scan after pancreaticoduodenectomy a useful tool in the early detection of complications? A single center retrospective analysis.

Authors:  Michele Mazzola; Pietro Calcagno; Alessandro Giani; Marianna Maspero; Camillo Leonardo Bertoglio; Paolo De Martini; Carmelo Magistro; Cristiano Sgrazzutti; Angelo Vanzulli; Giovanni Ferrari
Journal:  Langenbecks Arch Surg       Date:  2022-06-25       Impact factor: 3.445

7.  The Impact of CT-Assessed Liver Steatosis on Postoperative Complications After Pancreaticoduodenectomy for Cancer.

Authors:  Giovanni Guarneri; Diego Palumbo; Nicolò Pecorelli; Francesco Prato; Chiara Gritti; Raffaele Cerchione; Domenico Tamburrino; Stefano Partelli; Stefano Crippa; Michele Reni; Francesco De Cobelli; Massimo Falconi
Journal:  Ann Surg Oncol       Date:  2022-06-18       Impact factor: 4.339

8.  Lessons learned from 300 consecutive pancreaticoduodenectomies over a 25-year experience: the "safety net" improves the outcomes beyond surgeon skills.

Authors:  Roberto Santoro; Roberto Luca Meniconi; Pasquale Lepiane; Giovanni Vennarecci; Gianluca Mascianà; Marco Colasanti; Eugenio Santoro; Giuseppe Maria Ettorre
Journal:  Updates Surg       Date:  2017-09-01

Review 9.  Influence of Hospital Volume Effects and Minimum Caseload Requirements on Quality of Care in Pancreatic Surgery in Germany.

Authors:  Christian Krautz; Axel Denz; Georg F Weber; Robert Grützmann
Journal:  Visc Med       Date:  2017-03-30

10.  Portal vein resection in advanced pancreatic adenocarcinoma: is it worth the risk?

Authors:  Katharina Marsoner; Rainer Langeder; Dora Csengeri; Gottfried Sodeck; Hans Jörg Mischinger; Peter Kornprat
Journal:  Wien Klin Wochenschr       Date:  2016-06-30       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.